Sienna Diagnostics Inks Singapore Distribution Deal for Bladder Cancer Test

Jun

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

Jul

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Menu

Sienna Diagnostics Inks Singapore Distribution Deal for Bladder Cancer Test

To read the full story....

Breaking News

Liquid Biopsy Assay From MSKCC Approved by New York State

Federal Appeals Court Upholds Ruling Invalidating Enzo Biochem Patent

Cascade Testing for Dilated Cardiomyopathy Likely to Be Cost Effective, Analysis Finds

In Brief This Week: Bio-Techne, Molecular Testing Labs

Vermillion Ovarian Cancer Test Gets Coverage From BCBS of Texas, Arizona

Germany Agrees to Nationwide Reimbursement for Genomic Health Oncotype DX Breast Cancer Test

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

What's Popular?

Liquid Biopsy Assay From MSKCC Approved by New York State

AMP and CAP Comment on Palmetto Proposed Guidelines for NGS Testing of Myeloid Disorders

Liquid Biopsy Monitoring, Surveillance Efforts Accelerate Across Cancer Types and Technologies

Germany Agrees to Nationwide Reimbursement for Genomic Health Oncotype DX Breast Cancer Test

Adaptive Biotechnologies Expects Planned IPO to Fetch $15 to $17 a Share

Sponsorships